IMLFF News and Press, InMed Pharmaceuticals Inc. From 11/25/19

NEW YORK , Nov. 25, 2019 /PRNewswire/ -- Virtual Investor Conferences today announced the agenda for the upcoming Virtual lnvestor Conference, the leading proprietary investor conference series.  Individual investors, institutional investors, advisors and analysts are invited to...

InMed Pharmaceuticals to Present at the Cowen Conference Canada NewsWire VANCOUVER, Nov. 11, 2019 VANCOUVER , Nov. 11, 2019 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or "the Company") (TSX:IN; OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthes...

InMed Pharmaceuticals ( OTCQX:IMLFF ): Q1 GAAP EPS of -C$0.02. Cash and cash equivalents of C$14.7M Press Release More news on: InMed Pharmaceuticals Inc., Earnings news and commentary, Tech stocks news, ,

InMed Pharmaceuticals Reports First Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update InMed Pharmaceuticals Reports First Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update Canada NewsWire VANCOUVER, Nov. 8, 2019 VA...

InMed Submits Clinical Trial Application to Evaluate INM-755 in Phase 1 Trial Canada NewsWire VANCOUVER, Nov. 5, 2019 VANCOUVER , Nov. 5, 2019 /CNW/ -  InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN; OTCQX: IMLFF), today announced the filing of a Cli...

InMed Pharmaceuticals to Report First Quarter Fiscal 2020 Financial Results and Business Update on November 8, 2019 Canada NewsWire VANCOUVER, Nov. 4, 2019 VANCOUVER , Nov. 4, 2019 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a bi...

InMed Pharmaceuticals to Present at the BIO Investor Forum Canada NewsWire VANCOUVER, Oct. 18, 2019 VANCOUVER , Oct. 18, 2019 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynth...

InMed Pharmaceuticals (IMLFF) is a small-cap pre-clinical stage Canadian pharmaceutical company "focused on the therapeutic potential of cannabinoids" (i.e. the constituents of marijuana). InMed, despite its small size, is one of the more scientifically advanced companies in the area of medica...

InMed Pharmaceuticals to Present at the Regulatory Affairs Professionals Society's annual conference Canada NewsWire VANCOUVER, Sept. 23, 2019 VANCOUVER , Sept. 23, 2019 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or "the Company") (TSX:IN; OTCQX:IMLFF), a biopharmaceutic...

InMed Pharmaceuticals Inc. (IMLFF) Q4 2019 Earnings Conference Call September 19, 2019 10:00 AM ET Company Participants Bruce Colwill - Chief Financial Officer Eric Adams - President & Chief Executive Officer Alexandra Mancini - Senior Vice President of Clinical & Regulat...